17 reports

  • VINDICO NANOBIOTECHNOLOGY INC
  • LEISHMANIASIS VACCINE - DRUG PROFILE

Leishmaniasis (Kala-Azar) - Overview Leishmaniasis (Kala-Azar) - Therapeutics Development NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR LEISHMANIASIS (KALA-AZAR), H## 2017 PIPELINE OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR LEISHMANIASIS (KALA-AZAR), H## 2017 Phase III ## ## Phase II ## ## Phas

  • Pathology
  • Therapy
  • United States
  • World
  • Product Initiative
  • VINDICO NANOBIOTECHNOLOGY INC
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2018 (CONTD..1), H1 2018

Leishmaniasis (Kala-Azar) - Overview Leishmaniasis (Kala-Azar) - Therapeutics Development NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR LEISHMANIASIS (KALA-AZAR), H## 2018 PIPELINE OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR LEISHMANIASIS (KALA-AZAR), H## 2018 Phase III ## ## Phase II ## ## Phas

  • Pathology
  • Therapy
  • United States
  • World
  • Product Initiative
  • ZIKA VIRUS VACCINE - DRUG PROFILE

Zika Virus Infections - Overview Zika Virus Infections - Therapeutics Development NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR ZIKA VIRUS INFECTIONS, H## 2018 PIPELINE OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR ZIKA VIRUS INFECTIONS, H## 2018 Phase II ## ## Phase I ## ## IND/ CTA Filed

  • Pathology
  • Research And Development
  • Surgery
  • United States
  • Hemispherx Biopharma, Inc.
  • JUN 07, 2017: NEW CLASS OF DOUBLE-DUTY MAGNETIC NANOPARTICLES ENGINEERED TO LOWER CANCER'S DEFENSES WHILE FIRING UP IMMUNE SYSTEM

Genito Urinary System And Sex Hormones Hematological Disorders Hormonal Disorders Infectious Disease Male Health Mouth And Dental Disorders Nutritional Disorders Other Diseases Pharmaceuticals and Healthcare Women' s Health ## ## ## ## ## ## ##

  • Pathology
  • Pharmaceutical
  • Surgery
  • Therapy
  • United States
  • ZIKA VIRUS VACCINE - DRUG PROFILE

Zika Virus Infections - Overview Zika Virus Infections - Therapeutics Development NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR ZIKA VIRUS INFECTIONS, H## 2017 PIPELINE OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR ZIKA VIRUS INFECTIONS, H## 2017 Phase II ## ## Phase I ## ## Preclinical ## ## Disco

  • Pathology
  • Research And Development
  • Surgery
  • United States
  • Hemispherx Biopharma, Inc.
  • Jan 10, 2017: Engineering Nanomaterials to Deliver Precise Treatments for Heart Disease

The research was carried out at Northwestern' s Simpson Querrey Institute for BioNanotechnology.

  • Healthcare
  • Pathology
  • Surgery
  • Therapy
  • United States
  • Stage Of Development
  • BIOMARKER BASED DIAGNOSTIC ASSAY - CARDIAC DISEASE - PRODUCT DESCRIPTION

UCD offers inter-institutional collaborative programs and research centers in the areas which include sensor web technologies, systems biology and nanobiotechnology and biopharmaceuticals, among others.

  • Biomarker
  • Cardiovascular Disease
  • Clinical Trial
  • Pathology
  • Surgery

Further, the applications of different technologies like genomics, proteomics, nanobiotechnology, pharmacogenomics, etc are driving innovation within this market.

  • Pathology
  • North America
  • United States
  • bioMerieux S.A.
  • Cepheid

Note: ##.

  • Pathology
  • bioMerieux S.A.
  • Cepheid
  • Hologic, Inc.
  • Myriad Genetics, Inc.
  • Type1 diabetes (Juvenile Diabetes) - Companies Involved in Therapeutics Development

ORAL HDV-INSULIN USES A UNIQUE, BIONANOTECHNOLOGY BASED CELL TARGETING SYSTEM TO PREFERENTIALLY DELIVER INSULIN TO SPECIFIC SITES IN THE BODY.

  • Diabetes
  • Insulin
  • Pathology
  • Surgery
  • Therapy
  • UNIVERSITY COLLEGE DUBLIN PIPELINE PRODUCTS & ONGOING CLINICAL TRIALS OVERVIEW
  • MRM BASED BIOMARKER ASSAY - PROSTATE CANCER - PRODUCT STATUS

UCD offers inter-institutional collaborative programs and research centers in the areas which include sensor web technologies, systems biology and nanobiotechnology and biopharmaceuticals, among others.

  • Clinical Trial
  • Diagnostics
  • Pathology
  • Prostate Cancer
  • Surgery
  • TRETINOIN - DRUG PROFILE

Rituximab was given on day ## of cycles ##-## (Arm A), while obinutuzumab was given on days ##, ## and ## of cycle ## and day ## of cycles ##-## (Arm B).

  • Lymphoma
  • Pathology
  • Pharmaceutical
  • Surgery
  • Therapy
  • TRETINOIN - DRUG PROFILE

Group ## (G##) received ofatumumab on Day ## of Cycle ##, and Imbruvica on Day ## of Cycle ##.

  • Lymphoma
  • Pathology
  • Surgery
  • Targeted Therapy
  • Therapy

NANOBIOTECHNOLOGY JOINS THE BREAKTHROUGHS IN NANOTECHNOLOGY TO THOSE IN MOLECULAR BIOLOGY.

  • Pathology
  • Surgery
  • Market Size
  • Amgen Inc.
  • Merck & Co., Inc.
  • 3.7 PATENT TRENDS

New area of research called nanobiotechnology has also emerged.

  • Pathology
  • Surgery
  • World
  • Market Size
  • DePuy Synthes, Inc.

Note: ##.

  • Pathology
  • Cepheid
  • Myriad Genetics, Inc.
  • QIAGEN N.V.
  • Roche Group
  • UNIVERSITY COLLEGE DUBLIN PIPELINE PRODUCTS & ONGOING CLINICAL TRIALS OVERVIEW
  • Cardiac Markers Tests Companies and Product Overview

Consolidated net profit : € ## ##. ## million, equal to ## ##. ## % of revenues, + ##. ##% compared to € ## ##. ## million in 2013.

  • Chronic Disease
  • Clinical Trial
  • Pathology
  • Surgery
  • Company